for review and correction. At that time, physicians can review their reports and challenge them if they are false, inaccu- rate, or misleading. CMS says it will pro- vide physicians access to their consoli- dated financial disclosures for the prior calendar year. According to AMA, CMS will release
most of the data on a public website by September. AMA’s online toolkit, available at
http://bit.ly/1lYBWZG, features a webi- nar on preparing for the Sunshine Act, an overview of the financial interactions and ownership interests that will be re- ported, an explanation of the excluded financial interactions, answers to fre- quently asked questions, and a summary of the act’s key provisions. AMA advises physicians to:
• Ensure all financial and conflict-of- interest disclosures required by em- ployers and other entities that pro-
vide funding are current and updated regularly.
• Update professional information, and ensure the correct specialty has been designated.
• Learn what financial transfers and ownership interests must be reported by drug and device manufacturers and group purchasing organizations.
• Ask industry contacts to provide transfer information in advance to correct the information before it’s transmitted to the government.
The Open Payments Mobile for Phy-
sicians app allows you to capture and confidentially collect information on reportable transfers between you and industry representatives. Download the app on your Apple device at http://bit .ly/1kLWcem or on your Android device at
http://bit.ly/1j3iwNN. Note: The Sunshine Act stipulates payments for speaking at a continuing
medical education (CME) program are not required to be reported if the follow- ing conditions are met:
• The activity meets the accreditation or certification requirements of the continuing education accrediting agency, e.g., the Accreditation Coun- cil for Continuing Medical Education.
• The pharmaceutical or device compa- ny does not pay the speaker directly.
• The pharmaceutical or device com- pany does not choose the speaker or give the CME provider a group of speakers to consider for the activity.
Most of the information contained in
the reports will be available on a public, searchable website. n
Kara Nuzback is a reporter for Texas Medicine. You can reach her by telephone at (800) 880-1300, ext. 1393, or (512) 370-1393; by fax at (512) 370-1629; or by email at
kara.nuzback@
texmed.org.
How important is it to test your patients for prediabetes?
Very.
The problems that develop from diabetes can be devastating. Yet if you diagnose patients who have prediabetes and get them on the right track, it’s possible to prevent or delay type 2 diabetes — an important consideration, given that one in three adults is estimated to have prediabetes. Introduce your patients to
PreventType2.org where they’ll learn about lifestyle changes and have easy access to information on risk factors, health tips, and classes. Together we can prevent or delay diabetes.
Tell your patients to visit
PreventType2.org or
PrevenirTipo2.org for more information.
TDC-0488_TMA_7.1875x4.8125_V3_R1.indd 1 34 TEXAS MEDICINE July 2014
6/6/14 9:24 AM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68